BLIS Technologies Limited (NZE:BLT)

Market Cap	19.19M
Revenue (ttm)	12.78M
Net Income (ttm)	1.55M
Shares Out	1.28B
EPS (ttm)	0.00
PE Ratio	11.49
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	217,367
Average Volume	61,572
Open	0.0160
Previous Close	0.0160
Day's Range	0.0150 - 0.0160
52-Week Range	0.0110 - 0.0220
Beta	0.20
RSI	55.32
Earnings Date	Feb 25, 2025

About BLIS Technologies

BLIS Technologies Limited, together with its subsidiaries, develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity. The company offers BLIS K12, an oral probiotic supplement to support ear, nose, and throat health, as well as for enhancing immunity and bad breath; BLIS M18, an oral probiotic to support teeth and gums health; and BLIS Q24, a probiotic supplement to balance the skin microbiome, restoring the health, clarity, and radiance. It has operations in New Zealand, Asia Pacific, Europe, the Mid...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Employees: 39
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: BLT